Back
Pacira BioSciences Vs. Revance Therapeutics Industry Stock Comparison
Sell
33
PCRX
Pacira BioSciences
Last Price:
14.71
Seasonality Move:
-2.82%
Sell
21
RVNC
Revance Therapeutics
Last Price:
5.86
Seasonality Move:
-5.59%
Sell
33
Pacira BioSciences (PCRX)
is a Sell
Is Pacira BioSciences a Buy, Sell or Hold?
- The current Pacira BioSciences [PCRX] share price is $14.64. The Score for PCRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- PCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
21
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy, Sell or Hold?
- The current Revance Therapeutics [RVNC] share price is $5.99. The Score for RVNC is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- RVNC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PCRX Stock Price Chart
What is Pacira BioSciences's stock price today?
-
The Pacira BioSciences share price today is $14.64
The current trend is relatively stagnant and PCRX is experiencing slight selling pressure.
RVNC Stock Price Chart
What is Revance Therapeutics's stock price today?
-
The Revance Therapeutics share price today is $5.99
The current trend is moderately bearish and RVNC is experiencing slight selling pressure.
PCRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.87 | Sell |
Relative Strength Index (14 RSI): | 47.85 | Sell |
Chaikin Money Flow: | -36437 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
RVNC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.25 | Buy |
Relative Strength Index (14 RSI): | 48.82 | Sell |
Chaikin Money Flow: | -2917555 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
PCRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.47 | Buy |
20-day SMA: | 14.17 | Buy |
50-day SMA: | 16.86 | Sell |
200-day SMA: | 26.29 | Sell |
8-day EMA: | 13.9 | Buy |
20-day EMA: | 14.37 | Buy |
50-day EMA: | 17.04 | Sell |
200-day EMA: | 24.96 | Sell |
RVNC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.35 | Sell |
20-day SMA: | 6.49 | Sell |
50-day SMA: | 5.16 | Buy |
200-day SMA: | 5.05 | Buy |
8-day EMA: | 6.25 | Sell |
20-day EMA: | 6.21 | Sell |
50-day EMA: | 5.42 | Buy |
200-day EMA: | 6.59 | Sell |
Pacira BioSciences Earnings Growth & PCRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.11 per share, and an increase next year of $0.00 per share.
Revance Therapeutics Earnings Growth & RVNC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.54 per share, an increase next quarter of $0.40 per share, an increase this year of $2.64 per share, and an increase next year of $0.70 per share.
Pacira BioSciences Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Revance Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |